Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2000

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2006

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

pyrazoloacridine

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (8)

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

30322

Winship Cancer Institute of Emory University, Atlanta

48202

Josephine Ford Cancer Center at Henry Ford Health System, Detroit

35294-3295

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

02114-2617

Massachusetts General Hospital Cancer Center, Boston

27157-1030

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00006355 - Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter